Medicare Enrolled

Dr. Andrew Sable, M.D.

Gastroenterology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
9555 N KENDALL DR, Miami, FL 33176
3052737319
In practice since 2006 (19 years)
NPI: 1548293376 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sable from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sable? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sable

Dr. Andrew Sable is a gastroenterology in Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Sable performed 752 Medicare services across 649 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sable received a total of $16,716 from 56 pharmaceutical and/or device companies across 1091 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sable is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 47% volume in FL$ $16,716 industry payments

Medicare Practice Summary

Medicare Utilization ↗
752
Medicare services
Top 47% in FL for gastroenterology
649
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~40 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)216$100$348
Office visit, established patient (20-29 min)92$72$237
Upper GI endoscopy with biopsy70$80$1,178
Hospital follow-up visit, moderate complexity62$69$237
Colonoscopy with biopsy59$103$1,495
Removal of polyps or growths of large bowel using an endoscope with mechanical snare57$238$1,426
New patient office visit (45-59 min)54$127$542
Initial hospital admission, moderate complexity44$114$455
New patient office visit (30-44 min)34$83$358
Colorectal cancer screening; colonoscopy on individual at high risk22$198$1,113
New patient office or other outpatient visit, 15-29 minutes16$55$245
Office visit, established patient (10-19 min)14$47$142
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk12$208$1,112
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,716
Total received (2018-2024)
Avg $2,388/year across 7 years
Top 10% in FL for gastroenterology
56
Companies
1,091
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,532 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$184 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,450
2023
$2,854
2022
$2,631
2021
$2,287
2020
$1,784
2019
$2,201
2018
$2,509

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,519
Janssen Biotech, Inc.
$1,882
QOL Medical, LLC
$1,467
AbbVie Inc.
$1,160
ABBVIE INC.
$871
Takeda Pharmaceuticals U.S.A., Inc.
$785
Gilead Sciences, Inc.
$640
Celgene Corporation
$598
RedHill Biopharma Inc.
$432
GENZYME CORPORATION
$431
AbbVie, Inc.
$416
Ironwood Pharmaceuticals, Inc
$416
Ferring Pharmaceuticals Inc.
$413
Daiichi Sankyo Inc.
$411
Regeneron Healthcare Solutions, Inc.
$375
Ardelyx, Inc.
$352
Allergan Inc.
$334
Intercept Pharmaceuticals, Inc.
$265
IRONWOOD PHARMACEUTICALS, INC
$258
Nestle HealthCare Nutrition Inc.
$202
Braintree Laboratories, Inc.
$198
Merck Sharp & Dohme Corporation
$176
Boston Scientific Corporation
$148
AIMMUNE THERAPEUTICS, INC.
$145
VIVUS LLC
$126
Synergy Pharmaceuticals Inc
$125
Alfasigma USA, Inc.
$120
PENTAX of America, Inc.
$104
Medtronic USA, Inc.
$100
INTERCEPT PHARMACEUTICALS, INC.
$92
Ipsen Biopharmaceuticals, Inc
$88
Celltrion USA Inc.
$81
Lilly USA, LLC
$81
PFIZER INC.
$76
FUJIFILM Medical Systems USA, Inc.
$73
Prometheus Laboratories Inc.
$72
Amgen Inc.
$67
EVOKE PHARMA, INC.
$60
Romark Laboratories, LC
$50
Mallinckrodt Hospital Products Inc.
$47
Merck Sharp & Dohme LLC
$45
Phathom Pharmaceuticals, Inc.
$45
Janssen Scientific Affairs, LLC
$44
NESTLE HEALTHCARE NUTRITION INC.
$43
Allergan, Inc.
$38
Shire North American Group Inc
$37
Cumberland Pharmaceuticals, Inc.
$35
Evoke Pharma, Inc.
$34
Alnylam Pharmaceuticals Inc.
$26
Aries Pharmaceuticals, Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
Exact Sciences Corporation
$16
UCB, Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
E.R. Squibb & Sons, L.L.C.
$15
Madrigal Pharmaceuticals
$15
Top 3 companies account for 35.1% of total payments
Associated products mentioned in payments ›
ALINIA · ANDEXXA · APRISO · AVSOLA · Aemcolo · Amitiza · C2 CryoBalloon · CIMZIA · CLENPIQ · CREON · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DUOPA · DUPIXENT · ELEVIEW · ENTYVIO · EOHILIA · ESD - Core Endoscopy · EXALT Model D · Entyvio · GATTEX · GIMOTI · GIVLAARI · HUMIRA · Humira · IBSRELA · IMAGINA · INFLECTRA · INJECTAFER · INTERSTIM · IQIRVO · KRISTALOSE · Kristalose · LINZESS · Linzess · MAVYRET · MONOFERRIC · MOTEGRITY · MOTOFEN · MOVIPREP · Mavyret · Motegrity · OCALIVA · OMVOH · PANCREAZE · PLENVU · PREVYMIS · QSYMIA · Qsymia · REBYOTA · RELISTOR · RELISTOR ORAL · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TERLIVAZ · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for gastroenterology in FL.

Equivalent to $2,223 per 100 Medicare services performed
Looking for a gastroenterology in Miami?
Compare gastroenterologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
156
Per 100K population
5.8
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sable is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 10%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sable experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sable performed 216 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sable receive payments from pharmaceutical companies?
Yes. Dr. Sable received a total of $16,716 from 56 companies across 1,091 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sable's costs compare to other gastroenterologys in Miami?
Dr. Sable's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sable) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →